18th Annual Winter Seminar: Essential Psychopharmacology, 2015
Carl Salzman, MD
This course will provide a simplified and clinically relevant updated review of neurobiology and brain function. Areas of emphasis will be the psychopharmacology treatment of schizophrenia, bipolar disorder, depression, anxiety, sleep disorders and borderline personality. The effectiveness of atypical and conventional anti-psychotic drugs as well as potential new medications will be reviewed. Augmenting agents of schizophrenia will also be reviewed. The course will address strategies for bipolar patients who are noncompliant or treatment-resistant; approaches to the acutely psychotic, recovering psychotic patients, and the concept of early intervention. The role of medical switch versus augmentation strategies for treatment-resistant depression will be reviewed. Psychiatric medications for the elderly will be reviewed, including dosage adjustments for age, drug interactions, and sensitivity to side effects. The Role of psychopharmacology in the treatment of obsessive symptoms, panic symptoms, and traumatic syndromes will be emphasized. The course will emphasize the establishment and importance of therapeutic alliance when prescribing all psychotropic medications, the interplay between pharmacologic and non-pharmacologic treatments, benefits and hazards of prescriber/non-prescriber co-treatment relationships. Educational presentation will be in seminar format and include lectures, participants discussions, and Q&A
- Evaluate psychotropic drug treatment options with particular emphasis on recent advances and practical prescribing information;
- Analyze the latest research in neurobiology and brain function;
- Implement treatment strategies for depressive and bipolar patients, including bipolar patients who are noncompliant or treatment resistant;
- Incorporate evidence-based approaches to treating acutely psychotic and recovering psychotic patients;
- Determine when to implement medical switch versus augmentation strategies for treatment-resistant depression;
- Make dosage adjustments in the elderly for age, drug interactions, and sensitivity to side effects;
- Describe the role of psychopharmacology in the treatment of generalized anxiety disorder, obsessive symptoms, panic symptoms, and traumatic syndromes
- Describe the interplay between pharmacologic and non-pharmacologic treatments;
- Identify the mechanisms and treatment for alcohol and substance abuse disorders;
- Determine the role of antidepressants in the life cycle of women.
|MONDAY, FEBRUARY 23, 2015
9:00 am – 12:15 pm
|A simplified and clinically relevant review of neurobiology as it applies to clinical psychopharmacology; neurotransmission, synapses, second messengers; gene function and an introduction to gene/environment interaction and prevention; dual diagnosis. Q & A.|
|TUESDAY, FEBRUARY 24, 2015
9:00 am – 12:15 pm
|Biology and treatment of schizophrenia disorders: the new generation of antipsychotic drugs; clinical aspects of treatment: use of typical and atypical neuroleptics; concept of early intervention and prevention; dual diagnosis; treatment of bipolar disorders; Q &A.|
|WEDNESDAY, FEBRUARY 25, 2015
9:00 am – 12:15 pm
|Depression; Neurobiology of Depression; diagnostic heterogeneity; what constitutes response? value of tricyclics; SSRI’s in perspective; new antidepressants; combination and augmentation strategies; new approaches to the bipolar patient. Q & A.|
|THURSDAY, FEBRUARY 26, 2015
9:00 am – 12:15 pm
|Anxiety, + panic, + OCD: Which drug, when to use; how much and for how long? rational benzodiazepine use; non-benzodiazepine strategies; use of hypnotics; PTSD.
Q & A.
|FRIDAY, FEBRUARY 27, 2015
9:00 am – 12:15 pm
|Diagnostic diversity and realistic pharmacologic treatment; geriatrics; personality disorders: is there a role for psychopharmacology?; dual diagnosis: alcohol/substance abuse and psychiatric disorders; psychotherapeutic issues: dynamic, behavioral, supportive; psychodynamics of prescribing; diverse meaning of medications. Q & A.|
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
Physicians: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, is approved by the American Psychological Association to offer Continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, maintains responsibility for this program.
Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School, is an NBCC-Approved Continuing Education Provider (ACEP™) and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEP™ solely is responsible for all aspects of the program.” The winter seminar programs meet the criteria for 15 clock hours.
Social Workers: Application for social work continuing education credits has been submitted.
Nurses: The following programs have been approved by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. The Ohio Nurses Association is accredited as an approver of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation. These educational activities have been awarded 15.0 contact hours: Essential Psychopharmacology, 2015, Carl Salzman, MD; Psychopharmacology: A Master Class, Carl Salzman, MD; New Innovations for the Treatment of ADHD and Psychological Brain Health, John Ratey, MD The Florida Board of Nursing has approved Meditation and Visualization Practices for Everyday Living and to Enhance Peak Performance for 15 contact hours
Educators: Application has been made to Commonwealth of Massachusetts to offer Professional Development Points (PDP’s).
Please call Stacy Ruiz at 617-754-1265 or e-mail firstname.lastname@example.org for more information about your credit hours.